| SPON1 |
SPON1, KIAA0762, VSGP: Spondin-1 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.703 |
Evidence |
|
| CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
SPON1 |
SPON1, KIAA0762, VSGP: Spondin-1 precursor |
0.703 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PCMT1 |
PCMT1: Protein-L-isoaspartate(D-aspartate) O-methyltransferase |
0.703 |
Evidence |
|
| TOM1L1 |
TOM1L1, SRCASM: TOM1-like protein 1 |
GRAP |
GRAP: GRB2-related adapter protein |
0.703 |
Evidence |
|
| CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
0.703 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
HSPH1 |
HSPH1, HSP105, HSP110, KIAA0201: Heat shock protein 105 kDa |
0.703 |
Evidence |
|
| LDHB |
LDHB: L-lactate dehydrogenase B chain |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.703 |
Evidence |
|
| SERPINB13 |
SERPINB13, PI13: Serpin B13 |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.7 |
Evidence |
|
| FAT2 |
FAT2, CDHF8, KIAA0811, MEGF1: Protocadherin Fat 2 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.7 |
Evidence |
|
| WNT2B |
WNT2B, WNT13: Protein Wnt-2b precursor |
SFRP1 |
CDNA FLJ45402 fis, clone BRHIP3029409, moderately similar to Homo sapiens secret |
0.7 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.7 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.7 |
Evidence |
|
| RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.7 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.7 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.7 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.7 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.7 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.7 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.7 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.7 |
Evidence |
|
| GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.7 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
0.7 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.7 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.7 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
0.7 |
Evidence |
|